On Tuesday morning, GN Hearing's 2021 financial guidance was downgraded considerably due to delivery delays of components for the development of products, which were meant to be launched in the second half of the year.
The company has also decided to reorganize its research and development activities to increase the quality and predictability of delivery times.
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card required.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
"Real world" patient data documents the long-term effects of ALK vaccines
In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.
Y-mabs CEO has big ambitions: Wants to create the Tesla of biotech
CEO at Y-mabs Claus Møller sees the potential to create "the Tesla within biotechnology" in the Danish-American cancer company, as reported by Danish media Børsen.
Contact with consumers will secure continued growth in China, says Sonova
Hearing aid manufacturer Sonova says direct contact with consumers on the growing Chinese market will be the way forward to increase growth.
AGC's Japanese and Danish factories to produce German biotech firm's drug candidate
German 4teen4 has chosen AGC Biologics as contract developer for the clinical testing of its drug candidate, procizumab.
EMA begins rolling review of another Covid-19 vaccine
The European Medicines Agency will assess the potential vaccine being developed by Valneva as data trickles in.
KLIFO is looking for a talented and committed eTMF Manager for our Glostrup Office 
QA Manager, QA Commercial Operations, Ascendis Pharma 
Senior Director, Global Regulatory Lead 
Chemist for process development 
Regulatory documentation Specialist 
Application Manager (GxP Systems) 
Regulatory Science Specialist 
CMC Stability Specialist 
Procurement Manager 
Join us! And start to impact healthcare through innovation 
Medical Director 
Director Regulatory Affairs 
Nordic Field Sales Manager 
Clinical Trial Manager 
GxP QA Compliance Manager for Quality Assurance